Fondazione Policlinico Universitario A. Gemelli - IRCCS
Roma, Italy, 00168
NCT Number: NCT05963165
Thyroidectomy is the most common iatrogenic cause of vocal fold paralysis. Patients complain of hoarseness caused by incomplete glottic closure and have effort to raise vocal intensity with consequent elevation of the larynx and/or involvement of supraglottic structures in phonation. These compensation mechanisms result in a shift of the fundamental frequency towards more serious tones or falsetto voice emissions.
The first choice treatment is speech therapy which aims to obtain better glottic closure, preventing ankylosis of the crico-arytenoid joint. In order to promote better glottic closure without risking the onset or increase of dysfunctional compensation, the idea behind this project is to propose non-phonatory adduction exercises in the first post-operative week.
The primary objective of the study is to compare patients who will perform non-phonatory exercises in parallel with medical therapy for one week and patients who will perform standard medical therapy only during the first week.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Roma, Italy, 00168
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Muscle exercises that favor glottic adduction without vocal emissions
Time frame: 3 months
A videostrobolaryngoscopy will be performed. The recorded videos will be viewed by expert clinicians and a numerical score will be assigned relating to the degree of glottic adduction on a 7-point scale.
Time frame: 3 months
Through the use of the "Praat" software, on the reading of the piece "The desert" and on a sustained /a/ the Fundamental Frequency (F0, Hz) will be analysed.
Time frame: 3 months
Through the use of the "Praat" software, on the reading of the piece "The desert" and on a sustained /a/ the noise/harmonics ratio (NHR) will be analysed.
Time frame: 3 months
Through the use of the "Praat" software, on the reading of the piece "The desert" and on a sustained /a/ the Jitter (%) will be analysed.
Time frame: 3 months
Through the use of the "Praat" software, on the reading of the piece "The desert" and on a sustained /a/ the Shimmer ( %) will be analysed.
f
Time frame: 3 months
Through the use of the "Praat" software, on the reading of the piece "The desert" and on a sustained /a/ the minimum frequency (Flow) will be analysed.
Time frame: 3 months
Through the use of the "Praat" software, on the reading of the piece "The desert" and on a sustained /a/ the maximum frequency (Fhigh) will be analysed.
Time frame: 3 months
Through the use of the "Praat" software, on the reading of the piece "The desert" and on a sustained /a/ the intensity (dB) will be analysed.
Time frame: 3 months
the Maximum Phonatory Time (MPT) will be evaluated on a sustained /a/ (minimum 3 seconds)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Early Speech Therapy Using Non-phonatory Exercises in Patients with Unilateral Vocal Fols Paralysis After Thyroidectomy: a Randomized Clinical Trial
Acronym: ENFP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03906877
Cranial Nerve Diseases, Laryngeal Diseases
Brussels, Belgium
View Trial DetailsNCT03966183
Central Auditory Processing Disorder, Communication Disorders
Brussels, Belgium
View Trial DetailsNCT02407301
Cranial Nerve Diseases, Laryngeal Diseases
Gainesville, Florida, United States
View Trial DetailsNCT00597844
Cranial Nerve Diseases, Intrathoracic Malignancies
New York, United States
View Trial Details